Delivery Order SPE2DR25D3008-SPE2DR26F3P5E
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Prevymis 480 mg tablets in a seven-count package configuration. This firm fixed-price delivery order, valued at $9,946.92, represents a non-competitive award and is scheduled for completion by November 28, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Prevymis is an antiviral medication used in...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Prevymis 480 mg tablets in a quantity of seven units, with a contract ceiling value of $4,719.34 and an ultimate completion date of October 7, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Prevymis is an...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Prevymis 480 mg tablets (7-count) with a ceiling value of $9,438.70. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is set for ultimate completion by October 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Prevymis is an antiviral medication...
- The Defense Logistics Agency awarded a $4,973.46 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Prevymis 480 mg tablets (7-count units) on October 27, 2025, with completion targeted for November 18, 2025. This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $4,973.46 to AmerisourceBergen Drug Corp for the supply of Prevymis 480 mg tablets (7-count packaging), with performance to be completed by December 17, 2025. This non-competitive, firm fixed-price delivery order was awarded on November 25, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. Prevymis is an antiviral medication used primarily in immunocompromised populations, reflecting the federal...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $31,536.30 on January 15, 2026, by the Defense Logistics Agency (DLA) for the supply of Prevymis 480 mg tablets in quantities of seven. This firm fixed-price, non-set-aside contract is scheduled for completion by February 6, 2026, with performance taking place at the awardee's corporate office in Conshohocken, Pennsylvania. Prevymis is an antiviral medication used primarily to prevent...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Prevymis 480 mg tablets (quantity 7) valued at $4,719.34 under firm fixed pricing. The award was made on August 13, 2025, with an ultimate completion date of September 4, 2025. This non-set-aside contract represents a delivery order against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at approximately $1 billion through December 2026....
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Prevymis 480 mg tablets in packages of seven units. This firm fixed-price delivery order, valued at $4,719.34, represents a non-competitive set-aside award and is scheduled for completion by May 15, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Prevymis (letermovir) is an antiviral...
- The Defense Logistics Agency awarded a $4,719.34 firm fixed price delivery order to AmerisourceBergen Drug Corp for Prevymis 480 mg tablets (quantity 7) on June 18, 2025, with an ultimate completion date of July 11, 2025. This non-set-aside competitive award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Prevymis is an antiviral medication used to prevent cytomegalovirus infection in immunocompromised patients, representing part of the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $5,256.05 to AmerisourceBergen Drug Corp for the supply of Prevymis 480 mg tablets (7-count units) on January 8, 2026, with a completion date of January 30, 2026. This firm fixed-price, non-set-aside delivery order is being performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s existing Indefinite Delivery Contract with...
- SPE2DR25D3008Indefinite Delivery Contract
- SPE2DR25D3008-SPE2DR26F3P5EDelivery Order
The Defense Logistics Agency (DLA) awarded a $5,256.05 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 20, 2026, for the supply of Prevymis 480 mg tablets (7-count units). This is a non-set-aside, competitively awarded contract with an ultimate completion date of February 10, 2026, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Prevymis is an antiviral medication used primarily in immunocompromised patients, particularly those who have undergone hematopoietic cell or solid organ transplantation. This delivery order is issued under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. As a critical pharmaceutical distributor for federal medical procurement, AmerisourceBergen serves military healthcare systems, the Defense Health Agency, and other government medical institutions through this comprehensive contract vehicle that supports the delivery of specialty medications, brand-name and generic drugs, vaccines, and medical supplies globally. AmerisourceBergen's consistent competitive success in federal pharmaceutical procurement demonstrates its capability to meet the DLA's stringent requirements for medical product distribution across the military healthcare supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 1/19/26 |